{
  "ptid_time": "128_S_0245_2006-03-21",
  "img_path": "/data/qiuhui/data/adni/images/128_S_0245/2006-03-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 60,763 mm³, 116.5% above the reference mean. With a Z-score of 2.67 (99.6th percentile), this represents significant enlargement; hippocampal volume measures 8,005 mm³, 12.5% above the reference mean. With a Z-score of 1.15 (87.5th percentile), this represents mild enlargement; whole brain volume measures 1,039,760 mm³, 6.7% above the reference mean. With a Z-score of 0.84 (80.0th percentile), this represents normal volume ; entorhinal cortex volume measures 3,022 mm³, 17.7% below the reference mean. With a Z-score of -1.09 (13.8th percentile), this represents mild atrophy; fusiform gyrus volume measures 13,630 mm³, 19.9% below the reference mean. With a Z-score of -1.81 (3.5th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 24,913 mm³, 30.0% above the reference mean. With a Z-score of 2.60 (99.5th percentile), this represents significant enlargement. ",
  "text_data": "Age is 73.8 years. Gender is Female. Education: 10 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Major Surgical Procedures. MMSE: 27.0. Logical Memory: 6.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (suggesting possible atrophy-related CSF expansion) and moderate atrophy in the fusiform gyrus, alongside mild entorhinal cortex atrophy—both regions implicated in Alzheimer's pathology. However, hippocampal volume is mildly enlarged (unusual for AD), and the MMSE score of 27 is within normal limits, with no APOE4 risk allele.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (atypical hippocampal enlargement and normal MMSE introduce uncertainty, but fusiform/entorhinal atrophy and ventricular expansion suggest early neurodegeneration).  \n\n*Note: Follow-up with CSF biomarkers (e.g., Aβ42, p-tau) or amyloid PET would clarify if this is AD-related MCI or another etiology.*",
  "timestamp": "2025-07-26T13:42:13.771005"
}